Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRent ExpenseRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

National Healthcare (NHC) EBITDA (2016 - 2025)

National Healthcare's EBITDA history spans 16 years, with the latest figure at $33.1 million for Q4 2025.

  • For Q4 2025, EBITDA rose 14.55% year-over-year to $33.1 million; the TTM value through Dec 2025 reached $128.4 million, up 42.78%, while the annual FY2025 figure was $128.4 million, 42.78% up from the prior year.
  • EBITDA reached $33.1 million in Q4 2025 per NHC's latest filing, up from $30.4 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $34.1 million in Q2 2025 to a low of -$17.1 million in Q4 2022.
  • Average EBITDA over 5 years is $16.6 million, with a median of $14.7 million recorded in 2021.
  • Peak YoY movement for EBITDA: tumbled 287.26% in 2022, then skyrocketed 219.4% in 2023.
  • A 5-year view of EBITDA shows it stood at $9.1 million in 2021, then crashed by 287.26% to -$17.1 million in 2022, then soared by 219.37% to $20.4 million in 2023, then soared by 41.42% to $28.9 million in 2024, then grew by 14.55% to $33.1 million in 2025.
  • Per Business Quant, the three most recent readings for NHC's EBITDA are $33.1 million (Q4 2025), $30.4 million (Q3 2025), and $34.1 million (Q2 2025).